INDIA, September 15, 2023/EINPresswire.com/ — The global cell therapy technologies market size is projected to reach USD 7.8 billion by 2028 from USD 4.2 billion in 2023, at a CAGR of 13.3 % during the forecast period. Factors such as increasing government investments in cell-based research, rising incidence of chronic and infectious diseases, large no of oncology related cell therapy clinical trials, increasing GMP certification for cell therapy production facilities are likely to have positive impact on the market growth.
Get a FREE Sample Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1824086
“The process segment held the dominant share in the cell therapy technologies market”
Based on process, the global cell therapy technologies market is segmented into cell processing, cell preservation, distribution & handling, process monitoring & quality control. The cell processing segment held a dominant share in the market in 2022. Advancement in cell processing techniques is likely to have positive impact on the growth of the market.
“Biopharmaceutical and biotechnology companies segment accounted for the largest share of the application segment in 2022.”
Based on end users, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies, CROS & CMOS, research institutes & cell banks. In 2022, the biopharmaceutical and biotechnology companies segment accounted for the largest share of the cell therapy technologies market. The segment held the dominant share in the market owing to various factors such as the emphasis on increase in number of cell therapy manufacturing facilities by key market players and rising investment in research activities of cell therapy.
“Asia Pacific region is likely to grow at a faster pace.”
The cell therapy technologies market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Asia Pacific region is anticipated to grow at a significant CAGR during the forecast period. The growth of the region is majorly driven by the increasing government investments in cell-based research. The increasing demand for cell therapy instruments and products from China, India, and Japan due to the rising research funding for vaccine development and changing disease profiles supports market growth in the Asia Pacific. Furthermore, increasing incidence of chronic and infectious diseases, the rising geriatric population, and government initiatives for healthcare infrastructural improvements are some of the elements anticipated to account for positive impact on the market growth.
The primary interviews conducted for this report can be categorized as follows:
By Respondent: Supply Side- 70%, and Demand Side – 30%
By Designation (Supply Side): Managers – 45%, CXOs & Directors – 30%, Executives- 25%
By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%
List of Companies Profiled in the Report:
Thermo Fisher Scientific, Inc. (US)
Merck KGaA (Germany)
Danaher Corporation (US)
Lonza Group (Switzerland)
Terumo Bct, Inc Corporation (Japan) (Terumo BCT is part of Terumo Corporation)
Becton, Dickinson & Company (US)
Fresenius Se & co. KGaA (Germany)
Avantor Inc (US)
Corning Incorporated (US)
Fujifilm Irvine Scientific (Japan)
Maxcyte Inc. (US)
Werum Software & Systems AG (Part of Korber AG) (Germany)
Roosterbio Inc. (US)
Sirion Biotech Gmbh (Germany)
L 7 Informatics Inc. (US)
Miltenyi Biotech (Germany)
Steamcell Technologies Inc. (Canada)
GPI Iberia (Formerly Hemasoft) (Spain)
Organabio LLC. (US)
Ixcells Biotechnologies (US)
Wilson Wolf 2019 Manufacturing Corporation (US)
Direct Purchase at https://www.reportsnreports.com/purchase.aspx?name=1824086
This report provides a detailed picture of the cell therapy technologies market. It aims at estimating the size and future growth potential of the market across different segments, such as product, process, cell type, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.